The cartilage repair market size has grown rapidly in recent years. It will grow from $1.61 billion in 2025 to $1.81 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing incidence of joint injuries, growth in sports-related orthopedic conditions, rising adoption of surgical cartilage repair procedures, advancements in biomaterial development, expansion of orthopedic specialty clinics.
The cartilage repair market size is expected to see rapid growth in the next few years. It will grow to $2.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising investments in tissue engineering research, expansion of personalized orthopedic treatments, growing focus on biologic repair methods, increasing adoption of outpatient orthopedic procedures. Major trends in the forecast period include increasing adoption of cell-based cartilage repair therapies, rising use of stem cell and regenerative treatments, growing demand for minimally invasive repair procedures, expansion of scaffold-based regeneration technologies, enhanced focus on long-term joint preservation.
The rising number of road accidents and sports-related injuries is expected to drive the growth of the cartilage repair market in the coming years. Road accidents involve vehicles, pedestrians, or cyclists on public roads or streets. In comparison, sports-related injuries are those that occur during participation in various sports and physical activities. An increase in road accidents and sports-related injuries substantially contributes to the demand for cartilage repair procedures to restore damaged cartilage, relieve pain, and enhance joint function caused by such injuries. For example, in June 2025, the Transport Accident Commission, an Australia-based government agency, reported that between 1 July 2024 and 30 June 2025, 296 people lost their lives, up from 287 during the same period the previous year, representing an increase of 9 deaths. Consequently, the rise in road accidents and sports-related injuries is fueling the growth of the cartilage repair market.
Major companies in the cartilage repair market are developing advanced products, including biologic cartilage repair solutions, to enhance treatment options for cartilage damage and support natural healing. Biologic cartilage repair products are treatments derived from biological sources, such as cells, tissues, or growth factors, intended to repair or regenerate damaged cartilage. For example, in August 2024, Vericel, a US-based biotechnology company, launched MACI (autologous cultured chondrocytes on porcine collagen membrane) Arthro and received approval from a US federal agency for protecting public health. MACI Arthro is a novel biologic cartilage repair product designed to treat knee cartilage defects. This product enables surgeons to manage symptomatic full-thickness cartilage defects of the knee up to 4 cm² in size using minimally invasive techniques. MACI Arthro allows for the evaluation and preparation of the defect site through small incisions with custom-designed instruments, representing a significant improvement over traditional methods.
In January 2024, Smith & Nephew, a UK-based medical technology company, acquired CartiHeal for an undisclosed amount. Through this acquisition, Smith & Nephew aims to broaden its regenerative medicine portfolio, strengthen its expertise in advanced knee repair technologies, and speed up the development of innovative solutions for cartilage restoration. CartiHeal is an Israel-based medical device company focused on knee regeneration technologies that support cartilage repair and joint preservation.
Major companies operating in the cartilage repair market are Stryker Corporation, Zimmer Biomet Holdings Inc, Smith and Nephew plc, Arthrex Inc, CONMED Corporation, Vericel Corporation, Anika Therapeutics Inc, MEDIPOST Co Ltd, Histogenics Corporation, ISTO Technologies Inc, Regentis Biomaterials Ltd, CartiHeal Ltd, Aesculap AG, Medacta International SA, Mathys AG Bettlach, JRI Orthopaedics Ltd, Waldemar Link GmbH and Co KG, Teijin Nakashima Medical Co Ltd, BioPoly LLC, Orthocell Ltd.
North America was the largest region in the cartilage repair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage repair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cartilage repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cartilage repair market by increasing costs of imported biomaterials, cell culture media, surgical instruments, and specialized implants used in regenerative and non-cell-based treatments. Hospitals and orthopedic centers in North America and Europe are most affected due to reliance on imported advanced materials, while Asia-Pacific faces higher costs for technology transfer and device imports. These tariffs are increasing treatment costs and limiting procedure adoption. However, they are also encouraging domestic production of biomaterials, localized manufacturing of implants, and regional research investment in cartilage regeneration technologies.
The cartilage repair market research report is one of a series of new reports that provides cartilage repair market statistics, including cartilage repair industry global market size, regional shares, competitors with a cartilage repair market share, detailed cartilage repair market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage repair industry. This cartilage repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cartilage repair is a medical procedure aimed at treating and restoring damaged or injured cartilage tissue in the body. Cartilage is a connective tissue that covers the ends of bones in joints, functioning as a cushion and lubricant to enable smooth and pain-free movement. These procedures are intended to address damaged or injured areas and support the healing and regeneration of cartilage tissue.
The primary types of treatments in cartilage repair are cell-based and non-cell-based. Cell-based treatments involve medical therapies that use living cells. These treatments are applied to various sites, including the knee, hip, ankle, foot, and others, and encompass a range of applications, such as hyaline cartilage and fibrocartilage, utilized by different end-users including hospitals, clinics, ambulatory surgical centers (ACS), and others.
The cartilage repair market consists of revenues earned by entities by providing services such as arthroscopy, allograft transplantation, biologic treatments, stem cell therapies, and microfracture. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage repair market also includes sales of synthetic scaffolds, cartilage transplants, orthopedic implants, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cartilage repair market size is expected to see rapid growth in the next few years. It will grow to $2.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising investments in tissue engineering research, expansion of personalized orthopedic treatments, growing focus on biologic repair methods, increasing adoption of outpatient orthopedic procedures. Major trends in the forecast period include increasing adoption of cell-based cartilage repair therapies, rising use of stem cell and regenerative treatments, growing demand for minimally invasive repair procedures, expansion of scaffold-based regeneration technologies, enhanced focus on long-term joint preservation.
The rising number of road accidents and sports-related injuries is expected to drive the growth of the cartilage repair market in the coming years. Road accidents involve vehicles, pedestrians, or cyclists on public roads or streets. In comparison, sports-related injuries are those that occur during participation in various sports and physical activities. An increase in road accidents and sports-related injuries substantially contributes to the demand for cartilage repair procedures to restore damaged cartilage, relieve pain, and enhance joint function caused by such injuries. For example, in June 2025, the Transport Accident Commission, an Australia-based government agency, reported that between 1 July 2024 and 30 June 2025, 296 people lost their lives, up from 287 during the same period the previous year, representing an increase of 9 deaths. Consequently, the rise in road accidents and sports-related injuries is fueling the growth of the cartilage repair market.
Major companies in the cartilage repair market are developing advanced products, including biologic cartilage repair solutions, to enhance treatment options for cartilage damage and support natural healing. Biologic cartilage repair products are treatments derived from biological sources, such as cells, tissues, or growth factors, intended to repair or regenerate damaged cartilage. For example, in August 2024, Vericel, a US-based biotechnology company, launched MACI (autologous cultured chondrocytes on porcine collagen membrane) Arthro and received approval from a US federal agency for protecting public health. MACI Arthro is a novel biologic cartilage repair product designed to treat knee cartilage defects. This product enables surgeons to manage symptomatic full-thickness cartilage defects of the knee up to 4 cm² in size using minimally invasive techniques. MACI Arthro allows for the evaluation and preparation of the defect site through small incisions with custom-designed instruments, representing a significant improvement over traditional methods.
In January 2024, Smith & Nephew, a UK-based medical technology company, acquired CartiHeal for an undisclosed amount. Through this acquisition, Smith & Nephew aims to broaden its regenerative medicine portfolio, strengthen its expertise in advanced knee repair technologies, and speed up the development of innovative solutions for cartilage restoration. CartiHeal is an Israel-based medical device company focused on knee regeneration technologies that support cartilage repair and joint preservation.
Major companies operating in the cartilage repair market are Stryker Corporation, Zimmer Biomet Holdings Inc, Smith and Nephew plc, Arthrex Inc, CONMED Corporation, Vericel Corporation, Anika Therapeutics Inc, MEDIPOST Co Ltd, Histogenics Corporation, ISTO Technologies Inc, Regentis Biomaterials Ltd, CartiHeal Ltd, Aesculap AG, Medacta International SA, Mathys AG Bettlach, JRI Orthopaedics Ltd, Waldemar Link GmbH and Co KG, Teijin Nakashima Medical Co Ltd, BioPoly LLC, Orthocell Ltd.
North America was the largest region in the cartilage repair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage repair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cartilage repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cartilage repair market by increasing costs of imported biomaterials, cell culture media, surgical instruments, and specialized implants used in regenerative and non-cell-based treatments. Hospitals and orthopedic centers in North America and Europe are most affected due to reliance on imported advanced materials, while Asia-Pacific faces higher costs for technology transfer and device imports. These tariffs are increasing treatment costs and limiting procedure adoption. However, they are also encouraging domestic production of biomaterials, localized manufacturing of implants, and regional research investment in cartilage regeneration technologies.
The cartilage repair market research report is one of a series of new reports that provides cartilage repair market statistics, including cartilage repair industry global market size, regional shares, competitors with a cartilage repair market share, detailed cartilage repair market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage repair industry. This cartilage repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cartilage repair is a medical procedure aimed at treating and restoring damaged or injured cartilage tissue in the body. Cartilage is a connective tissue that covers the ends of bones in joints, functioning as a cushion and lubricant to enable smooth and pain-free movement. These procedures are intended to address damaged or injured areas and support the healing and regeneration of cartilage tissue.
The primary types of treatments in cartilage repair are cell-based and non-cell-based. Cell-based treatments involve medical therapies that use living cells. These treatments are applied to various sites, including the knee, hip, ankle, foot, and others, and encompass a range of applications, such as hyaline cartilage and fibrocartilage, utilized by different end-users including hospitals, clinics, ambulatory surgical centers (ACS), and others.
The cartilage repair market consists of revenues earned by entities by providing services such as arthroscopy, allograft transplantation, biologic treatments, stem cell therapies, and microfracture. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage repair market also includes sales of synthetic scaffolds, cartilage transplants, orthopedic implants, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cartilage Repair Market Characteristics
3. Cartilage Repair Market Supply Chain Analysis
4. Global Cartilage Repair Market Trends and Strategies
5. Cartilage Repair Market Analysis of End Use Industries
7. Global Cartilage Repair Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cartilage Repair Total Addressable Market (TAM) Analysis for the Market
9. Cartilage Repair Market Segmentation
10. Cartilage Repair Market Regional and Country Analysis
11. Asia-Pacific Cartilage Repair Market
12. China Cartilage Repair Market
13. India Cartilage Repair Market
14. Japan Cartilage Repair Market
15. Australia Cartilage Repair Market
16. Indonesia Cartilage Repair Market
17. South Korea Cartilage Repair Market
18. Taiwan Cartilage Repair Market
19. South East Asia Cartilage Repair Market
20. Western Europe Cartilage Repair Market
21. UK Cartilage Repair Market
22. Germany Cartilage Repair Market
23. France Cartilage Repair Market
24. Italy Cartilage Repair Market
25. Spain Cartilage Repair Market
26. Eastern Europe Cartilage Repair Market
27. Russia Cartilage Repair Market
28. North America Cartilage Repair Market
29. USA Cartilage Repair Market
30. Canada Cartilage Repair Market
31. South America Cartilage Repair Market
32. Brazil Cartilage Repair Market
33. Middle East Cartilage Repair Market
34. Africa Cartilage Repair Market
36. Cartilage Repair Market Competitive Landscape and Company Profiles
37. Cartilage Repair Market Other Major and Innovative Companies
40. Cartilage Repair Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Cartilage Repair Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cartilage repair market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cartilage repair? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cartilage repair market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Treatment Modality: Cell-Based; Non-Cell-Based2) By Site: Knee; Hip; Ankle And Foot; Other Application Sites
3) By Application: Hyaline Cartilage; Fibrocartilage
4) By End User: Hospital And Clinic; Ambulatory Surgical Center (ASC); Other End-Users
Subsegments:
1) By Cell-Based Treatments: Autologous Chondrocyte Implantation (ACI); Stem Cell Therapy; Matrix-Induced Autologous Chondrocyte Implantation (MACI)2) By Non-Cell-Based Treatments: Scaffold-Based Treatment; Osteochondral Grafts; Synthetic Implants
Companies Mentioned: Stryker Corporation; Zimmer Biomet Holdings Inc; Smith and Nephew plc; Arthrex Inc; CONMED Corporation; Vericel Corporation; Anika Therapeutics Inc; MEDIPOST Co Ltd; Histogenics Corporation; ISTO Technologies Inc; Regentis Biomaterials Ltd; CartiHeal Ltd; Aesculap AG; Medacta International SA; Mathys AG Bettlach; JRI Orthopaedics Ltd; Waldemar Link GmbH and Co KG; Teijin Nakashima Medical Co Ltd; BioPoly LLC; Orthocell Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cartilage Repair market report include:- Stryker Corporation
- Zimmer Biomet Holdings Inc
- Smith and Nephew plc
- Arthrex Inc
- CONMED Corporation
- Vericel Corporation
- Anika Therapeutics Inc
- MEDIPOST Co Ltd
- Histogenics Corporation
- ISTO Technologies Inc
- Regentis Biomaterials Ltd
- CartiHeal Ltd
- Aesculap AG
- Medacta International SA
- Mathys AG Bettlach
- JRI Orthopaedics Ltd
- Waldemar Link GmbH and Co KG
- Teijin Nakashima Medical Co Ltd
- BioPoly LLC
- Orthocell Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.81 Billion |
| Forecasted Market Value ( USD | $ 2.82 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
